Revenue: As of FY2025 Q2, the actual value is USD 54.31 M.

EPS: As of FY2025 Q2, the actual value is USD 0.

EBIT: As of FY2025 Q2, the actual value is USD -465 K.

Segment Revenue

• Payor Revenue: Increased by 35.3% to $40.5 million for the three months ended June 30, 2025, from $29.9 million for the same period in 2024. For the six months ended June 30, 2025, Payor revenue increased by 34.0% to $78.3 million from $58.5 million in 2024.
• DTE Revenue: Decreased by 2.3% to $9.4 million for the three months ended June 30, 2025, from $9.6 million in 2024. For the six months ended June 30, 2025, DTE revenue was $19.0 million compared to $19.5 million in 2024.
• Consumer Revenue: Decreased by 32.1% to $4.4 million for the three months ended June 30, 2025, from $6.5 million in 2024. For the six months ended June 30, 2025, Consumer revenue decreased by 32.0% to $9.2 million from $13.5 million in 2024.

Operational Metrics

• Net Loss: For the three months ended June 30, 2025, net loss was $541,000 compared to $474,000 in 2024. For the six months ended June 30, 2025, net loss was $223,000 compared to $1.94 million in 2024.
• Cost of Revenue: Increased by 23.7% to $30.9 million for the three months ended June 30, 2025, from $25.0 million in 2024. For the six months ended June 30, 2025, cost of revenue increased by 22.9% to $59.7 million from $48.6 million in 2024.
• Research and Development Expenses: Increased by 22.7% to $2.6 million for the three months ended June 30, 2025, from $2.1 million in 2024. For the six months ended June 30, 2025, R&D expenses decreased by 6.0% to $5.4 million from $5.7 million in 2024.
• Sales and Marketing Expenses: Increased by 7.7% to $14.3 million for the three months ended June 30, 2025, from $13.2 million in 2024. For the six months ended June 30, 2025, these expenses increased by 7.4% to $28.2 million from $26.2 million in 2024.
• General and Administrative Expenses: Decreased by 22.0% to $5.7 million for the three months ended June 30, 2025, from $7.3 million in 2024. For the six months ended June 30, 2025, these expenses decreased by 12.8% to $10.9 million from $12.5 million in 2024.

Cash Flow

• Net Cash Used in Operating Activities: Was -$1.59 million for the six months ended June 30, 2025, compared to $1.42 million provided by operating activities in 2024.
• Net Cash Used in Investing Activities: Was -$11.39 million for the six months ended June 30, 2025, compared to -$2.15 million in 2024.
• Net Cash Used in Financing Activities: Was -$9.37 million for the six months ended June 30, 2025, compared to -$8.26 million in 2024.

Future Outlook and Strategy

• Core Business Focus: The company plans to continue focusing on increasing Payor revenue by expanding the number of completed sessions and enhancing its platform to attract more Payor members.
• Non-Core Business: The company is strategically reducing its focus on Consumer revenue, as evidenced by the decline in Consumer active members and revenue, to concentrate resources on Payor and DTE segments.